Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomas.

Gore L, Rothenberg ML, O'Bryant CL, Schultz MK, Sandler AB, Coffin D, McCoy C, Schott A, Scholz C, Eckhardt SG.

Clin Cancer Res. 2008 Jul 15;14(14):4517-25. doi: 10.1158/1078-0432.CCR-07-1461. Epub 2008 Jun 25.

2.

Chidamide tablets: HDAC inhibition to treat lymphoma.

Xu Y, Zhang P, Liu Y.

Drugs Today (Barc). 2017 Mar;53(3):167-176. doi: 10.1358/dot.2017.53.3.2595452. Review.

PMID:
28447074
3.

Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor.

Boumber Y, Younes A, Garcia-Manero G.

Expert Opin Investig Drugs. 2011 Jun;20(6):823-9. doi: 10.1517/13543784.2011.577737. Epub 2011 May 10. Review.

Supplemental Content

Support Center